Ira Gore
Hematology & Oncology · Birmingham, ALNPI 1447275565
Payments from drug & device makers
$857,055in general payments, 2019–2025
Across 294 payments — averaging $2915.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$426K
- Merck$233K
- Astrazeneca UK Limited$82K
- Puma Biotechnology, Inc.$59K
- Sanofi US Services Inc.$32K
- AstraZeneca$23K
- plus $3K from 28 others
General payments by program year
19
20
21
22
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 53 | $425,596 |
| Merck | 36 | $233,171 |
| Astrazeneca UK Limited | 5 | $82,477 |
| Puma Biotechnology, Inc. | 3 | $58,896 |
| Sanofi US Services Inc. | 10 | $31,751 |
| AstraZeneca | 17 | $22,613 |
| Novartis | 27 | $405 |
| Johnson & Johnson(2 entities) | 36 | $394 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $328 |
| Amgen | 15 | $216 |
| Pharmacyclics LLC, An Abbvie Company | 10 | $148 |
| Tesaro, Inc. | 7 | $147 |
| Seagen Inc. | 6 | $98 |
| Genentech USA, Inc. | 5 | $81 |
| Exelixis Inc. | 5 | $79 |
| Lilly USA, LLC | 5 | $75 |
| Bristol Myers Squibb | 4 | $70 |
| Myriad Genetic Laboratories, Inc. | 4 | $60 |
| Eisai Inc. | 4 | $54 |
| Pfizer | 4 | $53 |
| Astellas Pharma US Inc | 3 | $52 |
| Epizyme, Inc. | 3 | $40 |
| Karyopharm Therapeutics Inc. | 2 | $31 |
| Bayer | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Gilead(2 entities) | 2 | $27 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Aurobindo Pharma USA, Inc. | 1 | $17 |
| Dova Pharmaceuticals | 1 | $16 |
| GSK | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Beigene USA, Inc. | 1 | $13 |
| Secura Bio, Inc. | 1 | $12 |
How this compares
$857,055 in reported general payments places this provider in the 85th percentile of 177 hematology & oncology providers in Alabama.
Other hematology & oncology in Birmingham
- Luciano CostaBirmingham$32.8M
- Amitkumar MehtaBirmingham$18.6M
- Erica Stringer-ReasorBirmingham$18.1M
- Susan BalBirmingham$11.3M
- Pankit VachhaniBirmingham$7.9M
- Mehmet AkceBirmingham$5.4M
- Mayur NarkhedeBirmingham$4.9M
- Christos VaklavasBirmingham$4.9M
- Lisle NabellBirmingham$3.3M
- Omer JamyBirmingham$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.